Preeclampsia Diagnostics Market Market Share

  • Report ID: 4412
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Preeclampsia Diagnostics Market Market Share

North American Market Forecast

The North America preeclampsia laboratory market is predicted to hold the largest market share of 35% during the forecast period. The growth of the market in the country is due to factors such as increasing focus on drug delivery services and vaccine discovery and development, recent advancements in biotechnology and pharmaceutical research as well as the presence of many suppliers. In Canada, growing awareness of maternal and fetal health care through the Canadian Fetal Health Surveillance Program and the Canadian Premature Babies Foundation (CPBF) has led to rapid adoption of screening productand s, pre-eclampsia testing in the laboratory at obstetrics departments.

Asia Pacific Market Statistics

 The market in the Asia Pacific region is expected to grow substantially during the time period between 2024-2037. The growth of this market can be attributed owing to increasing population of women in reproductive age in the region. Besides this, escalating research and development activities, growing technological advancements and presence of biotechnology companies in the region is boosting the market expansion of preeclampsia diagnostics market on the forecast period.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4412
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of preeclampsia diagnostics is evaluated at USD 1.42 billion.

Preeclampsia Diagnostics Market size was over USD 1.38 billion in 2024 and is anticipated to exceed USD 2.08 billion by the end of 2037, witnessing over 3.2% CAGR during the forecast period i.e., between 2025-2037. The growing prevalence of pre-termed births, increasing innovative tests development will drive the market growth.

North America industry is expected to hold largest revenue share of 35% by 2037, due to increasing focus on drug delivery services and vaccine discovery and development in the region.

The major players in the market are of Cardinal Health Inc., Diabetomics Inc., F. Hoffmann La Roche Ltd., Thermo Fisher Inc., Biora Therapeutics Inc, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample